Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance
AMJ Wensing, NM van Maarseveen, M Nijhuis - Antiviral research, 2010 - Elsevier
HIV protease plays a crucial role in the viral life cycle and is essential for the generation of
mature infectious virus particles. Detailed knowledge of the structure of HIV protease and its …
mature infectious virus particles. Detailed knowledge of the structure of HIV protease and its …
Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel
MS Hirsch, HF Günthard, JM Schapiro… - Clinical Infectious …, 2008 - academic.oup.com
Resistance to antiretroviral drugs remains an important limitation to successful human
immunodeficiency virus type 1 (HIV-1) therapy. Resistance testing can improve treatment …
immunodeficiency virus type 1 (HIV-1) therapy. Resistance testing can improve treatment …
[HTML][HTML] Viral proteases as therapeutic targets
T Majerová, J Konvalinka - Molecular aspects of medicine, 2022 - Elsevier
Some medically important viruses―including retroviruses, flaviviruses, coronaviruses, and
herpesviruses―code for a protease, which is indispensable for viral maturation and …
herpesviruses―code for a protease, which is indispensable for viral maturation and …
Bioengineering of plant (tri)terpenoids: from metabolic engineering of plants to synthetic biology in vivo and in vitro
Terpenoids constitute a large and diverse class of natural products that serve many
functions in nature. Most of the tens of thousands of the discovered terpenoids are …
functions in nature. Most of the tens of thousands of the discovered terpenoids are …
[HTML][HTML] HIV-1 drug resistance mutations: an updated framework for the second decade of HAART
RW Shafer, JM Schapiro - AIDS reviews, 2008 - ncbi.nlm.nih.gov
More than 200 mutations are associated with antiretroviral resistance to drugs belonging to
six licensed antiretroviral classes. More than 50 reverse transcriptase mutations are …
six licensed antiretroviral classes. More than 50 reverse transcriptase mutations are …
A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape
RJ Lebbink, DCM de Jong, F Wolters, EM Kruse… - Scientific reports, 2017 - nature.com
HIV presents one of the highest evolutionary rates ever detected and combination
antiretroviral therapy is needed to overcome the plasticity of the virus population and control …
antiretroviral therapy is needed to overcome the plasticity of the virus population and control …
[HTML][HTML] Retroviral proteases and their roles in virion maturation
J Konvalinka, HG Kräusslich, B Müller - Virology, 2015 - Elsevier
Proteolytic processing of viral polyproteins is essential for retrovirus infectivity. Retroviral
proteases (PR) become activated during or after assembly of the immature, non-infectious …
proteases (PR) become activated during or after assembly of the immature, non-infectious …
Emergence of HIV drug resistance during first-and second-line antiretroviral therapy in resource-limited settings
Introduction Antiretroviral therapy (ART) in resource-limited settings has expanded in the last
decade, reaching> 8 million individuals and reducing AIDS mortality and morbidity …
decade, reaching> 8 million individuals and reducing AIDS mortality and morbidity …
Absence of lenacapavir (GS-6207) phenotypic resistance in HIV gag cleavage site mutants and in isolates with resistance to existing drug classes
N Margot, R Ram, M Rhee… - Antimicrobial Agents and …, 2021 - Am Soc Microbiol
ABSTRACT Lenacapavir (LEN; GS-6207) is a potent first-in-class inhibitor of HIV-1 capsid
with long-acting properties and the potential for subcutaneous dosing every 3 months or …
with long-acting properties and the potential for subcutaneous dosing every 3 months or …
Molecular basis of human immunodeficiency virus drug resistance: an update
L Menéndez-Arias - Antiviral research, 2010 - Elsevier
Antiretroviral therapy has led to a significant decrease in human immunodeficiency virus
(HIV)-related mortality. Approved antiretroviral drugs target different steps of the viral life …
(HIV)-related mortality. Approved antiretroviral drugs target different steps of the viral life …